Opus Genetics enters change-in-control bonus agreements with four top executives

Opus Genetics, Inc.

Agreements cover CEO Dr. George Magrath, CFO Robert Gagnon, COO Joseph Schachle, CS&DO Dr. Ashwath Jayagopal.
Each agreement provides a gross-up payment for any excise tax under Section 4999 of the Code triggered by change of control.
Agreements were entered into on April 1, 2026; form filed as Exhibit 10.1.
Gross-up is designed to put executives in the same after-tax position as if the excise tax had not applied.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.